AlphaCrest Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-14,770
| Closed | -$653K | – | 565 |
|
|
2022
Q3 | $653K | Sell |
14,770
-21,677
| -59% | -$958K | 0.04% | 855 |
|
|
2022
Q2 | $1.35M | Sell |
36,447
-21,845
| -37% | -$809K | 0.07% | 520 |
|
|
2022
Q1 | $2.16M | Buy |
58,292
+5,385
| +10% | +$199K | 0.12% | 220 |
|
|
2021
Q4 | $1.61M | Buy |
52,907
+823
| +2% | +$25K | 0.06% | 557 |
|
|
2021
Q3 | $1.75M | Buy |
52,084
+32,724
| +169% | +$1.1M | 0.09% | 369 |
|
|
2021
Q2 | $772K | Buy |
+19,360
| New | +$772K | 0.03% | 781 |
|
|
2021
Q1 | – | Sell |
-4,842
| Closed | -$274K | – | 1239 |
|
|
2020
Q4 | $274K | Sell |
4,842
-7,403
| -60% | -$419K | 0.02% | 950 |
|
|
2020
Q3 | $581K | Buy |
12,245
+3,726
| +44% | +$177K | 0.06% | 505 |
|
|
2020
Q2 | $502K | Sell |
8,519
-12,362
| -59% | -$728K | 0.08% | 385 |
|
|
2020
Q1 | $987K | Buy |
20,881
+15,381
| +280% | +$727K | 0.12% | 280 |
|
|
2019
Q4 | $332K | Sell |
5,500
-5,200
| -49% | -$314K | 0.03% | 1009 |
|
|
2019
Q3 | $641K | Buy |
+10,700
| New | +$641K | 0.04% | 794 |
|